Stockcalc – Free Trial
Have a free look inside the StockCalc website at www.stockcalc.com
I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.
Fully Valued Stocks on NASDAQ
Today we are looking at companies that are considered fully valued based on the Analyst data in the StockCalc database.
In this table we can see the close price and target price for these companies along with the number of analysts covering the stock. We also have included the fiscal year for the target price as sometimes these analyst targets are not for the current or even the next fiscal year.
There can be a number of reasons why a company would be on this list. What is particularly interesting are companies with a large analyst following that make this list. We need to dig deeper into these companies to understand why the difference in price versus target.
Today’s Data on NASDAQ
Today’s data is for companies listed on the NASDAQ.
| Symbol | Name | Target Year | Close Price | Target Price Mean | Currency | Target Price # of Estimates |
|---|---|---|---|---|---|---|
| WDAY | Workday Inc | 2020 | 170.770000 | 155.6250 | USD | 8 |
| DXCM | DexCom Inc | 2019 | 150.820000 | 143.3333 | USD | 3 |
| CINF | Cincinnati Financial Corp | 2019 | 79.500000 | 71.0000 | USD | 2 |
| IEP | Icahn Enterprises LP | 2019 | 67.560000 | 53.0000 | USD | 1 |
| MKTX | MarketAxess Holdings Inc | 2019 | 218.300000 | 205.0000 | USD | 1 |
| CACC | Credit Acceptance Corp | 2019 | 424.960000 | 390.6667 | USD | 3 |
| IONS | Ionis Pharmaceuticals Inc | 2019 | 57.440000 | 51.0000 | USD | 2 |
| UBNT | Ubiquiti Networks Inc | 2019 | 104.610000 | 86.0000 | USD | 1 |
| FIVE | Five Below Inc | 2020 | 122.170000 | 118.3333 | USD | 3 |
| BRKR | Bruker Corp | 2019 | 34.270000 | 30.0000 | USD | 1 |
| VSAT | Viasat Inc | 2020 | 61.440000 | 45.0000 | USD | 1 |
| TREE | LendingTree Inc | 2019 | 278.550000 | 267.5000 | USD | 6 |
| AMCX | AMC Networks Inc | 2019 | 61.530000 | 56.2500 | USD | 4 |
| INOV | Inovalon Holdings Inc | 2019 | 14.390000 | 10.0000 | USD | 1 |
| MANT | Mantech International Corp | 2019 | 54.910000 | 48.0000 | USD | 1 |
| APPN | Appian Corp | 2019 | 31.780000 | 27.0000 | USD | 1 |
| OPI | Office Properties Income Trust | 2019 | 32.070000 | 28.0000 | USD | 1 |
| FRPT | Freshpet Inc | 2019 | 37.190000 | 32.0000 | USD | 1 |
| NTRI | Nutrisystem Inc | 2019 | 43.670000 | 40.0000 | USD | 2 |
| ATNI | ATN International Inc | 2019 | 75.170000 | 45.0000 | USD | 1 |
| TCMD | Tactile Systems Technology Inc | 2019 | 62.140000 | 55.0000 | USD | 1 |
| SNBR | Sleep Number Corp | 2019 | 34.240000 | 27.0000 | USD | 1 |
| APOG | Apogee Enterprises Inc | 2020 | 33.820000 | 30.0000 | USD | 1 |
| KFRC | Kforce Inc | 2019 | 32.770000 | 29.0000 | USD | 1 |
| SPNS | Sapiens International Corp NV | 2019 | 12.130000 | 5.0000 | USD | 1 |
Let’s look at a few companies…
Lets look at a couple of the companies on this list to get a better understanding of them.
WDAY:NAS Workday
http://www.workday.com
Workday has 10200 employees and is headquartered in United States.
Workday Inc is a SaaS provider offering enterprise resource planning, or ERP, software for medium and large enterprises. The company’s product portfolio is built around human capital and financial management software.
DXCM:NAS DexCom
http://www.dexcom.com
DexCom has 2990 employees and is headquartered in United States.
DexCom Inc designs, develops and commercializes continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients.
Free Valuation
Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.
The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.